FDA Refuses To File BLA For Cancer Gene Therapy

Advexin setback compounds dicey financial status of developmental company Introgen.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet